Dasatinib Accordpharma União Europeia - dinamarquês - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Spironolactone Ceva União Europeia - dinamarquês - EMA (European Medicines Agency)

spironolactone ceva

ceva santé animale - spironolacton - diuretika - hunde - til anvendelse i kombination med standardterapi (herunder diuretisk støtte, hvor det er nødvendigt) til behandling af kongestivt hjertesvigt forårsaget af valvular regurgitation hos hunde.

Lamivudine Teva Pharma B.V. União Europeia - dinamarquês - EMA (European Medicines Agency)

lamivudine teva pharma b.v.

teva b.v.  - lamivudin - hiv infektioner - antivirale midler til systemisk anvendelse - lamivudin teva pharma b. indikeres som en del af antiretroviral kombinationsbehandling til behandling af humane immunsvigt-virus (hiv) -inficerede voksne og børn.

Ledaga União Europeia - dinamarquês - EMA (European Medicines Agency)

ledaga

helsinn birex pharmaceuticals ltd. - chlormethine - mycosis fungoides - antineoplastiske midler - ledaga er indiceret til topisk behandling af mycosis fungoides-type kutant t-celle lymfom (mf-type ctcl) hos voksne patienter.

Cetraxal 2 mg/ml øredråber, opløsning i enkeltdosisbeholder Dinamarca - dinamarquês - Lægemiddelstyrelsen (Danish Medicines Agency)

cetraxal 2 mg/ml øredråber, opløsning i enkeltdosisbeholder

poa pharma scandinavia ab - ciprofloxacin - øredråber, opløsning i enkeltdosisbeholder - 2 mg/ml